Regulatory circuitry and mechanisms controlling cell fate in C. elegans
控制线虫细胞命运的调节电路和机制
基本信息
- 批准号:9908114
- 负责人:
- 金额:$ 58.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressCRISPR/Cas technologyCaenorhabditis elegansCell CommunicationCellsCongenital AbnormalityCuesData CollectionDevelopmentDevelopmental BiologyDiagnosticDiseaseEngineeringEpidermal Growth Factor ReceptorFosteringFoundationsGene ExpressionGeneticGonadal structureHealthHumanLobular NeoplasiaMalignant NeoplasmsMedicineMethodsMicrofluidicsMolecularMonitorPatternPhysiologicalPopulationRegulationSignal PathwaySignal TransductionSystemTechnologyTherapeuticTimeVulvaWorkbasecell fate specificationgene functiongenetic analysisgenetic approachhuman diseaseinsightlife historynotch proteinpersonalized medicineserial imagingtemporal measurementtool
项目摘要
Project Summary/Abstract
This proposal addresses how cells communicate with each other to control development by
elucidating the signaling components, modulators and mechanisms that govern cell-cell
interactions. Understanding the underlying genetic circuitry and molecular mechanisms is critical,
because aberrant activity of these same signaling pathways have profound effects on human
health, most notably as causal agents of cancer, congenital defects and diverse physiological
disorders. Regulating signaling appropriately—in space or cell population, in time, strength or
duration, or in combination with other signaling inputs—is thus crucial both for normal
development and for insight into human disease. This proposal builds on foundational work on
two key developmental paradigms in C. elegans: (i) specification of alternative cell fates by LIN-
12/Notch signaling in the gonad and (ii) the integration of LIN-12/Notch and EGFR-Ras-ERK
signaling to pattern three distinct fates in the vulva. Although each paradigm has unique
attributes, they provide a unified platform for elucidating regulatory circuitry and mechanisms
underlying cell fate decisions and the function and regulation of major, conserved signaling
systems. These C. elegans paradigms have a distinguished record of fostering discoveries that
are directly applicable to basic human developmental biology and medicine, and a major reason
is that they are especially amenable to genetic analysis. The proposed work will utilize a
combination of classical genetic approaches and CRISPR/Cas9-engineering and other
technologies to manipulate and monitor gene function, as well new microfluidic-based methods
for longitudinal imaging and automated data collection that allows unprecedented cellular
precision and temporal resolution in analyzing cell fate choice, gene expression, and signaling
dynamics. The work will address three key gaps in understanding: (i) the relationship between
signaling dynamics and cell fate specification, (ii) the regulatory circuitry and mechanisms that
enable precise and robust spatial patterning, and (iii) the regulation of developmental progression
through integrating life history and environmental cues with spatial patterning. The identification
of mechanisms by which major, conserved signaling systems are regulated and integrated with
each other is increasingly important in the era of personalized medicine and the deeper
understanding of developmental mechanism we will achieve through these studies will be
potentially applicable to developing diagnostic and therapeutic tools for human disease.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Iva S Greenwald其他文献
Iva S Greenwald的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Iva S Greenwald', 18)}}的其他基金
Regulatory circuitry and mechanisms controlling cell fate in C. elegans
控制线虫细胞命运的调节电路和机制
- 批准号:
10395484 - 财政年份:2019
- 资助金额:
$ 58.35万 - 项目类别:
Regulatory circuitry and mechanisms controlling cell fate in C. elegans
控制线虫细胞命运的调节电路和机制
- 批准号:
10610359 - 财政年份:2019
- 资助金额:
$ 58.35万 - 项目类别:
Regulatory circuitry and mechanisms controlling cell fate in C. elegans
控制线虫细胞命运的调节电路和机制
- 批准号:
10798385 - 财政年份:2019
- 资助金额:
$ 58.35万 - 项目类别:
Spatial, temporal and environmental regulation of early gonadogenesis in C. elegans
线虫早期性腺发生的空间、时间和环境调节
- 批准号:
9321881 - 财政年份:2015
- 资助金额:
$ 58.35万 - 项目类别:
Spatial, temporal and environmental regulation of early gonadogenesis in C. elegans
线虫早期性腺发生的空间、时间和环境调节
- 批准号:
9128674 - 财政年份:2015
- 资助金额:
$ 58.35万 - 项目类别:
New modes and mechanisms of negative regulation of LIN-12/Notch in C. elegans
线虫中LIN-12/Notch负调控的新模式和新机制
- 批准号:
9028823 - 财政年份:2015
- 资助金额:
$ 58.35万 - 项目类别:
New modes and mechanisms of negative regulation of LIN-12/Notch in C. elegans
线虫中LIN-12/Notch负调控的新模式和新机制
- 批准号:
9296137 - 财政年份:2015
- 资助金额:
$ 58.35万 - 项目类别:
New modes and mechanisms of negative regulation of LIN-12/Notch in C. elegans
线虫中LIN-12/Notch负调控的新模式和新机制
- 批准号:
9146963 - 财政年份:2015
- 资助金额:
$ 58.35万 - 项目类别:
Spatial, temporal and environmental regulation of early gonadogenesis in C. elegans
线虫早期性腺发生的空间、时间和环境调节
- 批准号:
8943717 - 财政年份:2015
- 资助金额:
$ 58.35万 - 项目类别:
Genes that influence LIN-12/Notch Activity in C. elegans
影响线虫 LIN-12/Notch 活性的基因
- 批准号:
7163547 - 财政年份:2003
- 资助金额:
$ 58.35万 - 项目类别:
相似海外基金
Integrating CRISPR-Cas Technology into Organic Electronics for Rapid Point-of-Care Genotyping
将 CRISPR-Cas 技术集成到有机电子器件中以实现快速护理点基因分型
- 批准号:
BB/X003442/1 - 财政年份:2023
- 资助金额:
$ 58.35万 - 项目类别:
Research Grant
Platform for CRISPR/Cas technology and AAV atherosclerosis model (S03)
CRISPR/Cas技术和AAV动脉粥样硬化模型平台(S03)
- 批准号:
408096640 - 财政年份:2018
- 资助金额:
$ 58.35万 - 项目类别:
Collaborative Research Centres














{{item.name}}会员




